CN111518960A - 一种用于冠状病毒分型检测的多重RT-qPCR试剂盒、引物探针组合物及其使用方法 - Google Patents
一种用于冠状病毒分型检测的多重RT-qPCR试剂盒、引物探针组合物及其使用方法 Download PDFInfo
- Publication number
- CN111518960A CN111518960A CN202010547290.7A CN202010547290A CN111518960A CN 111518960 A CN111518960 A CN 111518960A CN 202010547290 A CN202010547290 A CN 202010547290A CN 111518960 A CN111518960 A CN 111518960A
- Authority
- CN
- China
- Prior art keywords
- gene
- hcov
- probe
- seq
- sars
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000000523 sample Substances 0.000 title claims abstract description 68
- 238000001514 detection method Methods 0.000 title claims abstract description 43
- 241000711573 Coronaviridae Species 0.000 title claims abstract description 37
- 238000000034 method Methods 0.000 title claims abstract description 21
- 239000000203 mixture Substances 0.000 title claims abstract description 19
- 238000011529 RT qPCR Methods 0.000 title claims description 18
- 238000003762 quantitative reverse transcription PCR Methods 0.000 title claims description 18
- 230000003321 amplification Effects 0.000 claims abstract description 22
- 238000003199 nucleic acid amplification method Methods 0.000 claims abstract description 22
- 101150076800 B2M gene Proteins 0.000 claims abstract description 15
- 102000004190 Enzymes Human genes 0.000 claims abstract description 13
- 108090000790 Enzymes Proteins 0.000 claims abstract description 13
- 241001678559 COVID-19 virus Species 0.000 claims abstract description 12
- 241000482741 Human coronavirus NL63 Species 0.000 claims abstract description 8
- 210000002345 respiratory system Anatomy 0.000 claims abstract description 6
- 241000711467 Human coronavirus 229E Species 0.000 claims abstract 6
- 108090000623 proteins and genes Proteins 0.000 claims description 44
- 239000013612 plasmid Substances 0.000 claims description 43
- 238000006243 chemical reaction Methods 0.000 claims description 22
- 101100240079 Severe acute respiratory syndrome coronavirus 2 N gene Proteins 0.000 claims description 12
- 101100203795 Severe acute respiratory syndrome coronavirus 2 S gene Proteins 0.000 claims description 11
- 108020004707 nucleic acids Proteins 0.000 claims description 11
- 150000007523 nucleic acids Chemical class 0.000 claims description 11
- 102000039446 nucleic acids Human genes 0.000 claims description 11
- 101100240078 Severe acute respiratory syndrome coronavirus N gene Proteins 0.000 claims description 6
- 239000013642 negative control Substances 0.000 claims description 5
- 239000013641 positive control Substances 0.000 claims description 5
- 108010014303 DNA-directed DNA polymerase Proteins 0.000 claims description 2
- 102000016928 DNA-directed DNA polymerase Human genes 0.000 claims description 2
- AHCYMLUZIRLXAA-SHYZEUOFSA-N Deoxyuridine 5'-triphosphate Chemical compound O1[C@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)[C@@H](O)C[C@@H]1N1C(=O)NC(=O)C=C1 AHCYMLUZIRLXAA-SHYZEUOFSA-N 0.000 claims description 2
- 102100034343 Integrase Human genes 0.000 claims description 2
- 238000002123 RNA extraction Methods 0.000 claims description 2
- 108010092799 RNA-directed DNA polymerase Proteins 0.000 claims description 2
- 239000012295 chemical reaction liquid Substances 0.000 claims description 2
- 238000003745 diagnosis Methods 0.000 claims description 2
- 239000007788 liquid Substances 0.000 claims description 2
- 238000012216 screening Methods 0.000 claims description 2
- 125000006853 reporter group Chemical group 0.000 claims 7
- UDGUGZTYGWUUSG-UHFFFAOYSA-N 4-[4-[[2,5-dimethoxy-4-[(4-nitrophenyl)diazenyl]phenyl]diazenyl]-n-methylanilino]butanoic acid Chemical compound COC=1C=C(N=NC=2C=CC(=CC=2)N(C)CCCC(O)=O)C(OC)=CC=1N=NC1=CC=C([N+]([O-])=O)C=C1 UDGUGZTYGWUUSG-UHFFFAOYSA-N 0.000 claims 6
- 238000010791 quenching Methods 0.000 claims 6
- 230000000171 quenching effect Effects 0.000 claims 6
- 201000010099 disease Diseases 0.000 claims 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 3
- FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 claims 1
- 101150104466 NOCT gene Proteins 0.000 claims 1
- 238000004458 analytical method Methods 0.000 claims 1
- 230000035945 sensitivity Effects 0.000 abstract description 13
- 244000309467 Human Coronavirus Species 0.000 abstract description 8
- 241001109669 Human coronavirus HKU1 Species 0.000 abstract description 6
- 238000012544 monitoring process Methods 0.000 abstract description 6
- 241001428935 Human coronavirus OC43 Species 0.000 abstract description 5
- 241000315672 SARS coronavirus Species 0.000 abstract description 5
- 230000000694 effects Effects 0.000 abstract description 5
- 238000000605 extraction Methods 0.000 abstract description 5
- 239000000443 aerosol Substances 0.000 abstract description 3
- 238000003753 real-time PCR Methods 0.000 abstract description 2
- 238000010839 reverse transcription Methods 0.000 abstract description 2
- 239000000243 solution Substances 0.000 description 10
- 230000004544 DNA amplification Effects 0.000 description 7
- 101001024647 Severe acute respiratory syndrome coronavirus Nucleoprotein Proteins 0.000 description 5
- 201000003176 Severe Acute Respiratory Syndrome Diseases 0.000 description 3
- 241000700605 Viruses Species 0.000 description 3
- 239000003153 chemical reaction reagent Substances 0.000 description 3
- 244000000010 microbial pathogen Species 0.000 description 3
- 238000012360 testing method Methods 0.000 description 3
- 241000124740 Bocaparvovirus Species 0.000 description 2
- 241001647372 Chlamydia pneumoniae Species 0.000 description 2
- 241000606153 Chlamydia trachomatis Species 0.000 description 2
- 208000000059 Dyspnea Diseases 0.000 description 2
- 206010013975 Dyspnoeas Diseases 0.000 description 2
- 241000709661 Enterovirus Species 0.000 description 2
- 241000712431 Influenza A virus Species 0.000 description 2
- 241000713196 Influenza B virus Species 0.000 description 2
- 241000351643 Metapneumovirus Species 0.000 description 2
- 241000202934 Mycoplasma pneumoniae Species 0.000 description 2
- 208000002606 Paramyxoviridae Infections Diseases 0.000 description 2
- 241000725643 Respiratory syncytial virus Species 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- 229940038705 chlamydia trachomatis Drugs 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 230000000241 respiratory effect Effects 0.000 description 2
- 208000023504 respiratory system disease Diseases 0.000 description 2
- 208000001528 Coronaviridae Infections Diseases 0.000 description 1
- 206010011224 Cough Diseases 0.000 description 1
- 206010035664 Pneumonia Diseases 0.000 description 1
- 206010037660 Pyrexia Diseases 0.000 description 1
- 208000001647 Renal Insufficiency Diseases 0.000 description 1
- 238000007792 addition Methods 0.000 description 1
- 230000005540 biological transmission Effects 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 201000006370 kidney failure Diseases 0.000 description 1
- 239000013558 reference substance Substances 0.000 description 1
- 208000013220 shortness of breath Diseases 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 241000701161 unidentified adenovirus Species 0.000 description 1
- 239000013598 vector Substances 0.000 description 1
- 238000012795 verification Methods 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
- C12Q1/701—Specific hybridization probes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6844—Nucleic acid amplification reactions
- C12Q1/686—Polymerase chain reaction [PCR]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/16—Primer sets for multiplex assays
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/166—Oligonucleotides used as internal standards, controls or normalisation probes
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Zoology (AREA)
- Engineering & Computer Science (AREA)
- Wood Science & Technology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Microbiology (AREA)
- Molecular Biology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biophysics (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- Physics & Mathematics (AREA)
- General Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Genetics & Genomics (AREA)
- Virology (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
Description
RT-qPCR反应体系 | 加样量(杜L) |
RT-qPCR反应液 | 14 |
RT-qPCR酶液 | 1 |
待检测的核酸样本/阴阳对照品 | 5 |
总体积 | 20 |
样本编号 | FAM | ROX | Cy5 | VIC |
S1 | 26.33 | 24.56 | Undetermined | 29.01 |
S2 | Undetermined | Undetermined | 30.41 | 33.13 |
S3 | Undetermined | Undetermined | 29.34 | 30.43 |
S4 | Undetermined | Undetermined | 28.84 | 25.67 |
S5 | Undetermined | Undetermined | 26.86 | 28.45 |
S6 | Undetermined | Undetermined | Undetermined | 29.34 |
病原微生物 | FAM | ROX | Cy5 | VIC |
甲型流感病毒 | Undetermined | Undetermined | Undetermined | Undetermined |
副流感病毒 | Undetermined | Undetermined | Undetermined | Undetermined |
偏肺病毒 | Undetermined | Undetermined | Undetermined | Undetermined |
乙型流感病毒 | Undetermined | Undetermined | Undetermined | Undetermined |
呼吸道合胞病毒 | Undetermined | Undetermined | Undetermined | Undetermined |
鼻病毒 | Undetermined | Undetermined | Undetermined | Undetermined |
博卡病毒 | Undetermined | Undetermined | Undetermined | Undetermined |
肺炎衣原体 | Undetermined | Undetermined | Undetermined | Undetermined |
沙眼衣原体 | Undetermined | Undetermined | Undetermined | Undetermined |
肺炎支原体 | Undetermined | Undetermined | Undetermined | Undetermined |
腺病毒 | Undetermined | Undetermined | Undetermined | Undetermined |
Claims (10)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202010547290.7A CN111518960A (zh) | 2020-06-16 | 2020-06-16 | 一种用于冠状病毒分型检测的多重RT-qPCR试剂盒、引物探针组合物及其使用方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202010547290.7A CN111518960A (zh) | 2020-06-16 | 2020-06-16 | 一种用于冠状病毒分型检测的多重RT-qPCR试剂盒、引物探针组合物及其使用方法 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN111518960A true CN111518960A (zh) | 2020-08-11 |
Family
ID=71909932
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202010547290.7A Pending CN111518960A (zh) | 2020-06-16 | 2020-06-16 | 一种用于冠状病毒分型检测的多重RT-qPCR试剂盒、引物探针组合物及其使用方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN111518960A (zh) |
Cited By (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN111808997A (zh) * | 2020-08-27 | 2020-10-23 | 圣湘生物科技股份有限公司 | 检测10种呼吸道相关病毒并分型的组合物、试剂盒、用途及方法 |
CN112029906A (zh) * | 2020-08-27 | 2020-12-04 | 中国检验检疫科学研究院 | 一种基于SNP区分SARS-CoV和SARS-CoV2病毒的二维码检测方法 |
CN112779357A (zh) * | 2021-01-15 | 2021-05-11 | 上海捷诺生物科技有限公司 | 人冠状病毒核酸多重检测试剂盒 |
CN113025752A (zh) * | 2021-03-24 | 2021-06-25 | 广州金域医学检验中心有限公司 | 用于2019-nCoV和SARS病毒PCR检测的内参基因、试剂盒及检测方法 |
CN113493856A (zh) * | 2020-04-02 | 2021-10-12 | 宁波海尔施基因科技有限公司 | 一种用于冠状病毒检测分型的多重rt-pcr试剂盒、方法及引物组 |
CN113817871A (zh) * | 2021-09-15 | 2021-12-21 | 岛津企业管理(中国)有限公司 | 冠状病毒的检测方法及试剂盒 |
CN114480727A (zh) * | 2020-11-12 | 2022-05-13 | 台达电子国际(新加坡)私人有限公司 | 检测人类冠状病毒感染力的方法 |
CN115044703A (zh) * | 2021-11-22 | 2022-09-13 | 江汉大学 | 一种人冠状病毒HCoV-OC43的MNP标记位点、引物组合物、试剂盒及其应用 |
CN115044705B (zh) * | 2021-11-22 | 2023-06-16 | 江汉大学 | 一种人冠状病毒HCoV-NL63的MNP标记位点、引物组合物、试剂盒及其应用 |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102732638A (zh) * | 2011-04-07 | 2012-10-17 | 中山大学 | 人冠状病毒oc43、229e、nl63、hku1和sars一管多重荧光pcr检测方法及其引物、探针和试剂盒 |
CN110982942A (zh) * | 2020-03-02 | 2020-04-10 | 圣湘生物科技股份有限公司 | 检测冠状病毒并分型的组合物、试剂盒、方法及其用途 |
CN111100954A (zh) * | 2020-02-08 | 2020-05-05 | 中华人民共和国无锡海关 | 同时检测包括2019-nCoV在内的四种人冠状病毒的四重荧光定量检测试剂盒 |
CN111270013A (zh) * | 2020-03-12 | 2020-06-12 | 宁波海尔施基因科技有限公司 | 一种检测2019新型冠状病毒的多重实时荧光定量pcr试剂盒、方法及引物探针组合物 |
-
2020
- 2020-06-16 CN CN202010547290.7A patent/CN111518960A/zh active Pending
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102732638A (zh) * | 2011-04-07 | 2012-10-17 | 中山大学 | 人冠状病毒oc43、229e、nl63、hku1和sars一管多重荧光pcr检测方法及其引物、探针和试剂盒 |
CN111100954A (zh) * | 2020-02-08 | 2020-05-05 | 中华人民共和国无锡海关 | 同时检测包括2019-nCoV在内的四种人冠状病毒的四重荧光定量检测试剂盒 |
CN110982942A (zh) * | 2020-03-02 | 2020-04-10 | 圣湘生物科技股份有限公司 | 检测冠状病毒并分型的组合物、试剂盒、方法及其用途 |
CN111270013A (zh) * | 2020-03-12 | 2020-06-12 | 宁波海尔施基因科技有限公司 | 一种检测2019新型冠状病毒的多重实时荧光定量pcr试剂盒、方法及引物探针组合物 |
Cited By (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN113493856A (zh) * | 2020-04-02 | 2021-10-12 | 宁波海尔施基因科技有限公司 | 一种用于冠状病毒检测分型的多重rt-pcr试剂盒、方法及引物组 |
CN113493856B (zh) * | 2020-04-02 | 2024-04-16 | 宁波海尔施基因科技股份有限公司 | 一种用于冠状病毒检测分型的多重rt-pcr试剂盒、方法及引物组 |
CN112029906A (zh) * | 2020-08-27 | 2020-12-04 | 中国检验检疫科学研究院 | 一种基于SNP区分SARS-CoV和SARS-CoV2病毒的二维码检测方法 |
CN112029906B (zh) * | 2020-08-27 | 2021-06-11 | 中国检验检疫科学研究院 | 一种基于SNP区分SARS-CoV和SARS-CoV2病毒的二维码检测方法 |
CN111808997A (zh) * | 2020-08-27 | 2020-10-23 | 圣湘生物科技股份有限公司 | 检测10种呼吸道相关病毒并分型的组合物、试剂盒、用途及方法 |
CN114480727A (zh) * | 2020-11-12 | 2022-05-13 | 台达电子国际(新加坡)私人有限公司 | 检测人类冠状病毒感染力的方法 |
CN112779357A (zh) * | 2021-01-15 | 2021-05-11 | 上海捷诺生物科技有限公司 | 人冠状病毒核酸多重检测试剂盒 |
CN112779357B (zh) * | 2021-01-15 | 2022-01-28 | 上海捷诺生物科技有限公司 | 人冠状病毒核酸多重检测试剂盒 |
CN113025752B (zh) * | 2021-03-24 | 2023-07-21 | 广州金域医学检验中心有限公司 | 用于2019-nCoV和SARS病毒PCR检测的内参基因、试剂盒及检测方法 |
CN113025752A (zh) * | 2021-03-24 | 2021-06-25 | 广州金域医学检验中心有限公司 | 用于2019-nCoV和SARS病毒PCR检测的内参基因、试剂盒及检测方法 |
CN113817871A (zh) * | 2021-09-15 | 2021-12-21 | 岛津企业管理(中国)有限公司 | 冠状病毒的检测方法及试剂盒 |
CN113817871B (zh) * | 2021-09-15 | 2024-02-09 | 岛津企业管理(中国)有限公司 | 冠状病毒的检测方法及试剂盒 |
CN115044705B (zh) * | 2021-11-22 | 2023-06-16 | 江汉大学 | 一种人冠状病毒HCoV-NL63的MNP标记位点、引物组合物、试剂盒及其应用 |
CN115044703B (zh) * | 2021-11-22 | 2024-03-22 | 江汉大学 | 一种人冠状病毒HCoV-OC43的MNP标记位点、引物组合物、试剂盒及其应用 |
CN115044703A (zh) * | 2021-11-22 | 2022-09-13 | 江汉大学 | 一种人冠状病毒HCoV-OC43的MNP标记位点、引物组合物、试剂盒及其应用 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN111020064B (zh) | 新型冠状病毒ORF1ab基因核酸检测试剂盒 | |
CN111518960A (zh) | 一种用于冠状病毒分型检测的多重RT-qPCR试剂盒、引物探针组合物及其使用方法 | |
CN111270013A (zh) | 一种检测2019新型冠状病毒的多重实时荧光定量pcr试剂盒、方法及引物探针组合物 | |
CN111254228B (zh) | 一种检测新型冠状病毒和流感病毒的试剂盒 | |
EP4202064A1 (en) | Kit and method for isothermal rapid detection of sars-cov-2 virus nucleic acid | |
CN112063756B (zh) | 多重检测呼吸道病毒核酸的方法及试剂盒 | |
CN113493856B (zh) | 一种用于冠状病毒检测分型的多重rt-pcr试剂盒、方法及引物组 | |
CN111663007A (zh) | 一种多种病毒核酸联合检测引物与探针组合以及检测试剂盒 | |
CN111719016A (zh) | 检测新冠病毒2019-nCoV以及甲型、乙型流感病毒的组合物及应用 | |
CN113652505B (zh) | 检测新型冠状病毒及其voc-202012/01突变株的方法和试剂盒 | |
CN116024208B (zh) | 一种单次反应可同时检测26种猪疫病的试剂盒 | |
CN113774168A (zh) | 2019新型冠状病毒及其德尔塔和拉姆达变异株分型核酸检测试剂盒及检测方法 | |
CN113462820A (zh) | 实时荧光定量检测四种猪腹泻病毒的多重rt-pcr引物探针组、试剂盒及其检测方法 | |
CN109234456B (zh) | 一种可同时检测6种呼吸道病原体的试剂盒及其应用 | |
CN114107574A (zh) | 检测新型冠状病毒及其Omicron突变株的试剂盒和方法 | |
CN113025734A (zh) | 鉴别布鲁氏菌疫苗株a19与野毒株的引物、探针及应用 | |
CN111893215A (zh) | 一种检测冠状病毒多重real-time PCR试剂盒、方法和应用 | |
CN111926114A (zh) | 一种检测副流感病毒多重real-time PCR试剂盒、方法和应用 | |
CN110656163A (zh) | 一种双标记报告荧光多重病原体核酸检测方法 | |
CN112501358B (zh) | 一种用于检测9种儿童消化道病原体的引物探针组合及试剂盒 | |
CN113388701A (zh) | 引物探针组合物及其在制备副流感病毒分型检测试剂盒中的应用 | |
CN112921126A (zh) | 一种人呼吸道合胞病毒分型检测多重RT-qPCR试剂盒、引物探针组合物及其使用方法 | |
CN111471800B (zh) | 检测新型冠状病毒的试剂盒及其扩增引物组合物 | |
CN113278730B (zh) | 一种新型冠状病毒检测试剂盒、用途及其使用方法 | |
CN112226539A (zh) | 一种诺如病毒核酸检测试剂盒 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
CB02 | Change of applicant information | ||
CB02 | Change of applicant information |
Address after: 396 Mingzhu Road, science and Technology Park, Ningbo City, Zhejiang Province Applicant after: Ningbo Health Gene Technologies Co.,Ltd. Applicant after: Hebei children's Hospital Applicant after: HEBEI GENERAL Hospital Address before: 050000 No.133 jianhuanan street, Shijiazhuang, Hebei Province Applicant before: Hebei children's Hospital Applicant before: HEBEI GENERAL Hospital Applicant before: Ningbo Health Gene Technologies Co.,Ltd. |
|
CB02 | Change of applicant information | ||
CB02 | Change of applicant information |
Address after: 396 Mingzhu Road, science and Technology Park, Ningbo City, Zhejiang Province Applicant after: Ningbo Haier Shi Gene Technology Co.,Ltd. Applicant after: Hebei children's Hospital Applicant after: HEBEI GENERAL Hospital Address before: 396 Mingzhu Road, science and Technology Park, Ningbo City, Zhejiang Province Applicant before: Ningbo Health Gene Technologies Co.,Ltd. Applicant before: Hebei children's Hospital Applicant before: HEBEI GENERAL Hospital |
|
WD01 | Invention patent application deemed withdrawn after publication | ||
WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20200811 |